A literature review for updating the National Consensus Statement: Essential elements for safe and high-quality end-of-life care beyond acute care and during a pandemic.

The Commission has appointed Conjoint Professor Anne Duggan as the Commission’s new Chief Executive Officer. Professor Duggan has more than 30 years’ experience in the health sector and took on the role of CEO from 27 March 2023.

The standard outlines framework for the communication of pathology information within the request-test-report cycle.

This standard, together with the Tier 2 document Requirements for medical pathology services, sets out the expected policies, procedures and practices laboratories are to use when packaging and transporting pathology specimens and associated materials.

The standard sets out the expected level of practice required by laboratories for heritable and non-heritable human genetic variation medical testing.

This standard outlines practice standards that assure the safety, quality and efficacy of transfusion testing, associated transfusion laboratory practice, and non-transfusion related blood group immunohaematology testing. 

This guidance for health service organisations provides options and strategies for conserving medicines primarily in the acute care setting.